COPD trials in Türkiye
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffect of Telenursing on Oral Health
- Where
- Çanakkale
- Age
- 40 years and over
- People
- 80
- Run by
- Çanakkale Onsekiz Mart University
See details and how to joinNCT07462221 - Phase 2Taking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Adana, Ankara, Bursa, İzmit, Kayseri, Mersin
- Age
- 40 years and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - Phase 3Taking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Mersin
- Age
- 40 years to 80 years
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Adana, Ankara, Istanbul, Kayseri, Kocaeli, Mersin
- Age
- 40 years to 80 years
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - Phase 3Taking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Antalya, Çanakkale, Denizli, Izmir, İzmit
- Age
- 40 years to 80 years
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - Phase 3Taking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Adana, Afyonkarahisar, Antalya, Bursa, Çanakkale, Çankaya, Isparta, Istanbul, Izmir, Kayseri, Kocaeli, Mersin, Tekirdağ, Zeytinburnu
- Age
- 40 years to 80 years
- People
- 5,250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peopleThe CATALINA Study
- Where
- Ankara
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Wim Janssens
See details and how to joinNCT05008081